A Study in Healthy People to Test How Vicadrostat Affects the Heart

NCT07513207 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2026-05-12

No results posted yet for this study

Summary

The main objective of this trial is to investigate the effect of vicadrostat on the heart compared with placebo in healthy male and female volunteers.

Conditions

  • Healthy

Interventions

DRUG

Vicadrostat

Vicadrostat

DRUG

Placebo matching Vicadrostat

Placebo matching Vicadrostat

DRUG

Moxifloxacin

Moxifloxacin

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-22
Primary Completion
2026-07-24
Completion
2026-08-21

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07513207 on ClinicalTrials.gov